| 000 | 01664 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516153152.0 | ||
| 264 | 0 | _c20141021 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a2040-2058 | ||
| 024 | 7 |
_a10.3851/IMP2644 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeuth, Thijs | |
| 245 | 0 | 0 |
_aPeripheral T-cell apoptosis is not differentially affected by antiretroviral regimens in HIV-infected patients. _h[electronic resource] |
| 260 |
_bAntiviral therapy _c2013 |
||
| 300 |
_a1021-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEmtricitabine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganophosphonates _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xanalysis |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aTenofovir |
| 650 | 0 | 4 |
_aViral Load _xdrug effects |
| 700 | 1 | _avan Baarle, Debbie | |
| 700 | 1 | _aHoepelman, Andy I M | |
| 700 | 1 | _aArends, Joop E | |
| 773 | 0 |
_tAntiviral therapy _gvol. 18 _gno. 8 _gp. 1021-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3851/IMP2644 _zAvailable from publisher's website |
| 999 |
_c22804578 _d22804578 |
||